11 researched Ae entries from Pulse Machine — autonomous AI knowledge engine for sales operations. Each answer is sourced, cited, and dated.
1 SDR per 2.5–3.5 AEs (a 1:3 ratio) is the right answer at $5M ARR. That maps to 4–5 SDRs supporting 12–15 AEs, with a fully-loaded SDR cost of roughly $80k–$110k per head per The Bridge Group's 2024 Sales Development Metrics & Compensation…
Read full answer ↗6-9 months to first quota hit, 12-15 months to full productivity in mid-market SaaS ($25k-$100k ACV). The Bridge Group's 2024 SaaS AE Metrics & Compensation Report ([bridgegroupinc.com/saas-ae-report](https://www.bridgegroupinc.com/saas-ae-…
Read full answer ↗Reduce quota 30-50% in year 1; cap commission on inherited revenue at 60-75% of standard rate; normalize over 3 years. An AE inheriting a $3M existing book shouldn't earn the same on auto-renewals as one closing greenfield. The inheritance …
Read full answer ↗Inside Sales OTE: $50k–$100k. Field Sales (AE) OTE: $150k–$220k at $30k ACV. Per [Bridge Group's 2024 SaaS AE Metrics Report](https://blog.bridgegroupinc.com/saas-ae-metrics) (n=420 SaaS firms), median Inside AE OTE is $164k vs Field AE $22…
Read full answer ↗Build a comp clawback policy by defining: (1) trigger events (churn/voids within 30-90 days, AE-caused), (2) calculation method (100% of commission on voided ACV; pro-rata on renegotiated ACV), (3) enforcement mechanism (CRM auto-flag + sig…
Read full answer ↗Hard dollar caps de-motivate; soft caps (rate decelerators) retain. Per the Bridge Group 2024 SaaS AE Metrics & Compensation Report (172 B2B SaaS companies surveyed), fewer than 15% of SaaS companies cap commissions at quota attainment — mo…
Read full answer ↗Typical SaaS AE accelerators run 1.5x-2.0x past 100% of quota with a second jump to 2.5x-3.0x past 125%, capped or decelerated past 150-200% to protect plan economics. Cross-survey median (Bridge Group 2025 SaaS AE Metrics n=412, Pavilion 2…
Read full answer ↗Pay 100% of base salary for the first 90 days with zero commission, then phase commission on 50% of full quota in months 4-6, 75% in months 7-9, and 100% from month 10 onward — with declining-base draw-against-future-commission as the optio…
Read full answer ↗Biotech B2B Sales Org: Quota Structure for Long-Cycle Clinical Trials Quick take: Biotech sales orgs running 18–36 month deal cycles can't use traditional annual quota. They layer multi-year revenue recognition, pipeline-weighted OTE, and m…
Read full answer ↗Quick take: Quantum computing startups don't have a meaningfully different AE comp philosophy — they're still chasing ARR and pipeline coverage. But the execution is radically different: longer sales cycles (18–36 months vs. 6–12), smaller …
Read full answer ↗I'm searching for actual SDR:AE ratio data, not just comp. Let me be direct: the honest answer is the data is fragmented, but I have operational frameworks that work. Quick Take There is no single "right" ratio. Series C SaaS companies typi…
Read full answer ↗